These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21398079)

  • 1. [Ovarian hyperstimulation syndrome].
    Le Gouez A; Naudin B; Grynberg M; Mercier FJ
    Ann Fr Anesth Reanim; 2011 Apr; 30(4):353-62. PubMed ID: 21398079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on management of ovarian hyperstimulation syndrome.
    Chen CD; Wu MY; Chao KH; Lien YR; Chen SU; Yang YS
    Taiwan J Obstet Gynecol; 2011 Mar; 50(1):2-10. PubMed ID: 21482366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ovarian hyperstimulation syndrome in medically assisted reproduction].
    Rogé P; Erny R
    Rev Fr Gynecol Obstet; 1994 Oct; 89(10):495-501. PubMed ID: 7817078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ovarian hyperstimulation syndrome. Current concepts].
    Kably Ambe A; Sinibaldi Gómez J; Rosete Rossetti R; Barrón Vallejo J; Serviere Zaragoza C; Villavicencio Castañeda J
    Ginecol Obstet Mex; 1994 Apr; 62():98-102. PubMed ID: 8034223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of ovarian hyperstimulation syndrome.
    Dourron NE; Williams DB
    Semin Reprod Endocrinol; 1996 Nov; 14(4):355-65. PubMed ID: 8988530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ovarian hyperstimulation syndrome--prevention and treatment].
    Grønlund LA; Bogstad JW
    Ugeskr Laeger; 1996 Dec; 158(50):7205-9. PubMed ID: 9012033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Update on ovarian hyperstimulation syndrome].
    Delbaere A; Rodesch C; Englert Y
    Rev Med Brux; 1995 Nov; 16(5):354-60. PubMed ID: 7501911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiology and pathology of ovarian hyperstimulation syndrome.
    Gómez R; Soares SR; Busso C; Garcia-Velasco JA; Simón C; Pellicer A
    Semin Reprod Med; 2010 Nov; 28(6):448-57. PubMed ID: 21082502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and management of ovarian hyperstimulation syndrome.
    Chen CD; Chen SU; Yang YS
    Best Pract Res Clin Obstet Gynaecol; 2012 Dec; 26(6):817-27. PubMed ID: 22647872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility].
    Bangsbøll S
    Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
    Tozer AJ; Iles RK; Iammarrone E; Gillott CM; Al-Shawaf T; Grudzinskas JG
    Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of osmoregulation in the pathophysiology and management of severe ovarian hyperstimulation syndrome.
    Evbuomwan I
    Hum Fertil (Camb); 2013 Sep; 16(3):162-7. PubMed ID: 24047195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on ovarian hyperstimulation syndrome: Part 1--Incidence and pathogenesis.
    Binder H; Dittrich R; Einhaus F; Krieg J; Müller A; Strauss R; Beckmann MW; Cupisti S
    Int J Fertil Womens Med; 2007; 52(1):11-26. PubMed ID: 17987884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and management of ovarian hyperstimulation syndrome.
    Vlahos NF; Gregoriou O
    Ann N Y Acad Sci; 2006 Dec; 1092():247-64. PubMed ID: 17308149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian hyperstimulation syndrome management strategies: where are we going?
    Eskew AM; Omurtag KR
    Minerva Endocrinol; 2018 Mar; 43(1):50-56. PubMed ID: 28322539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic risk in assisted reproductive technology].
    Alatri A; Tribout B; Gencer B; Calanca L; Mazzolai L
    Rev Med Suisse; 2011 Feb; 7(281):357-60. PubMed ID: 21416715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the high-risk patient for ovarian hyperstimulation syndrome.
    Papanikolaou EG; Humaidan P; Polyzos NP; Tarlatzis B
    Semin Reprod Med; 2010 Nov; 28(6):458-62. PubMed ID: 21082503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
    Pau E; Alonso-Muriel I; Gómez R; Novella E; Ruiz A; García-Velasco JA; Simón C; Pellicer A
    Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ovarian overstimulation syndrome: problem of intensive care].
    Korneeva IE; Veriaeva NA; Gel'fand BR; Churadze BT
    Anesteziol Reanimatol; 2007; (6):59-63. PubMed ID: 18326263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.